 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Mark Greenwald and Michael P Blair.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.776 |
|
|
|
-
Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.194
-
Blair M, Gonzalez JMG, Snyder L, Schechet S, Greenwald M, Shapiro M, Rodriguez SH. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248.
Score: 0.185
-
Garcia Gonzalez JM, Snyder L, Blair M, Rohr A, Shapiro M, Greenwald M. PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
Score: 0.179
-
Yanoga F, Garcia-Gonzalez JM, Greenwald M, Shapiro MJ, Blair MP. CANDIDA ENDOPHTHALMITIS FROM THE REACTIVATION OF A DORMANT LENTICULAR FUNGAL ABSCESS IN A PREMATURE INFANT. Retin Cases Brief Rep. 2017 Summer; 11(3):269-271.
Score: 0.170
-
Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|